Invention Grant
- Patent Title: Anti-CD40 antibodies
-
Application No.: US16031209Application Date: 2018-07-10
-
Publication No.: US11242394B2Publication Date: 2022-02-08
- Inventor: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agency: Foley & Lardner LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K9/00 ; C07K1/22 ; A61K39/00
Abstract:
The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
Public/Granted literature
- US20190169301A1 ANTI-CD40 ANTIBODIES Public/Granted day:2019-06-06
Information query
